Manufacturer of Controlled Substances; Notice of Registration, 44861-44862 [E7-15507]
Download as PDF
<![CDATA[
44861
Federal Register / Vol. 72, No. 153 / Thursday, August 9, 2007 / Notices
basic classes of controlled substances
listed in schedule II:
Drug
Schedule
Lisdexamfetamine (1205) .............
Remifentanil (9739) ......................
II
II
The company plans to manufacture
the listed controlled substances in bulk
for sale to its customers.
Any other such applicant and any
person who is presently registered with
DEA to manufacture such substances
may file comments or objections to the
issuance of the proposed registration
pursuant to 21 CFR 1301.33(a). Any
such comments or objections being sent
via regular mail should be addressed, in
quintuplicate, to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), Washington, DC 20537; or any
being sent via express mail should be
sent to the Drug Enforcement
Administration, Office of Diversion
Control, Federal Register Representative
(ODL), 2401 Jefferson-Davis Highway,
Alexandria, Virginia 22301; and must be
filed no later than October 9, 2007.
and determined that the registration of
Noramco, Inc. to import the basic
classes of controlled substances is
consistent with the public interest and
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated
Noramco, Inc. to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to 21 U.S.C. 952(a)
and 958(a), and in accordance with 21
CFR 1301.34, the above named company
is granted registration as an importer of
the basic classes of controlled
substances listed.
Dated: August 1, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15514 Filed 8–8–07; 8:45 am]
Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15499 Filed 8–8–07; 8:45 am]
BILLING CODE 4410–09–P
BILLING CODE 4410–09–P
Importer of Controlled Substances;
Notice of Registration
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Drug Enforcement Administration
Importer of Controlled Substances;
Notice of Registration
By Notice dated April 17, 2007 and
published in the Federal Register on
April 30, 2007, (72 FR 21298), Noramco
Inc., 500 Swedes Landing Road,
Wilmington, Delaware 19801, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Schedule
mstockstill on PROD1PC66 with NOTICES
Raw Opium (9600) .......................
Concentrate of Poppy Staw
(9670).
II
II
The company plans to import the
listed controlled substances to
manufacture other controlled
substances.
No comments or objections have been
received. DEA has considered the
factors in 21 U.S.C. 823(a) and 952(a)
VerDate Aug<31>2005
18:25 Aug 08, 2007
Jkt 211001
Dated: July 31, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15515 Filed 8–8–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
DEPARTMENT OF JUSTICE
Drug
with United States obligations under
international treaties, conventions, or
protocols in effect on May 1, 1971, at
this time. DEA has investigated Penick
Corporation to ensure that the
company’s registration is consistent
with the public interest. The
investigation has included inspection
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to Title 21, U.S.C.
952(a) and 958(a), and in accordance
with Title 21, Code of Federal
Regulations (CFR) § 1301.34, the above
named company is granted registration
as an importer of the basic classes of
controlled substances listed.
By Notice dated May 10, 2007 and
published in the Federal Register on
May 18, 2007, (72 FR 28077), Penick
Corporation, 33 Industrial Park Road,
Pennsville, New Jersey 08070, made
application by renewal to the Drug
Enforcement Administration (DEA) to
be registered as an importer of the basic
classes of controlled substances listed in
schedule II:
Drug
Schedule
Coca Leaves (9040) .....................
Raw Opium (9600) .......................
Poppy Straw (9650) .....................
Concentrate of Poppy Straw
(9670).
II
II
II
II
The company plans to import the
listed controlled substances to
manufacture bulk controlled substance
intermediates for sale to its customers.
No comments or objections have been
received. DEA has considered the
factors in Title 21, United States Code
(U.S.C.) § 823(a) and § 952(a) and
determined that the registration of
Penick Corporation to import the basic
classes of controlled substances is
consistent with the public interest and
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
Manufacturer of Controlled
Substances; Notice of Registration
By Notice dated March 9, 2007, and
published in the Federal Register on
March 23, 2007 (72 FR 13825), Sigma
Aldrich Research, Biochemicals, Inc., 1–
3 Strathmore Road, Natick,
Massachusetts 01760, made application
by letter to the Drug Enforcement
Administration (DEA) to be registered as
a bulk manufacturer of the basic classes
of controlled substances listed in
schedule I:
Drug
Psilocybin (7437) ..........................
5-Methoxy-N,Ndiisopropyltyptamine (7439).
Schedule
I
I
The company plans on manufacturing
reference standards for research
purposes only.
No comments or objections have been
received. DEA has considered the
factors in Title 21, United States Code
(U.S.C.) 823(a) and determined that the
registration of Sigma Aldrich Research,
Biochemicals, Inc. to manufacture the
listed basic class of controlled substance
is consistent with the public interest at
this time. DEA has investigated Sigma
Aldrich Research, Biochemicals, Inc. to
ensure that the company’s registration is
consistent with the public interest. The
investigation has included inspection
E:\FR\FM\09AUN1.SGM
09AUN1
44862
Federal Register / Vol. 72, No. 153 / Thursday, August 9, 2007 / Notices
New information shows that leased
workers of Westaff were employed onsite at the Peoria, Illinois location of
Bemis Company, Inc., Paper Packaging
Division. The Department has
determined that the Westaff workers
were sufficiently under the control of
Bemis Company, Inc. to be considered
leased workers.
Based on these findings, the
Department is amending this
certification to include leased workers
of Westaff working on-site at the Peoria,
Illinois location of the subject firm.
The intent of the Department’s
certification is to include all workers
employed at Bemis Company, Inc.,
Paper Packaging Division, including onsite leased workers of Westaff, Peoria,
Illinois who were adversely affected by
a shift in production to Mexico.
The amended notice applicable to
TA–W–59,414 is hereby issued as
follows:
and testing of the company’s physical
security systems, verification of the
company’s compliance with state and
local laws, and a review of the
company’s background and history.
Therefore, pursuant to Title 21, U.S.C.
823, and in accordance with Title 21,
Code of Federal Regulations (CFR)
1301.33, the above named company is
granted registration as a bulk
manufacturer of the basic class of
controlled substance listed.
Dated: August 1, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of
Diversion Control, Drug Enforcement
Administration.
[FR Doc. E7–15507 Filed 8–8–07; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF LABOR
Employment and Training
Administration
[TA–W–59,414]
Bemis Company, Inc. Paper Packaging
Division Including On-Site Leased
Workers of Westaff, Peoria, IL;
Amended Certification Regarding
Eligibility To Apply for Worker
Adjustment Assistance and Alternative
Trade Adjustment Assistance
In accordance with section 223 of the
Trade Act of 1974 (19 U.S.C. 2273), and
section 246 of the Trade Act of 1974 (26
U.S.C. 2813), as amended, the
Department of Labor issued a
Certification of Eligibility to Apply for
Worker Adjustment Assistance and
Alternative Trade Adjustment
Assistance on June 8, 2006, applicable
to workers of Bemis Company, Inc.,
Paper Packaging Division, Peoria,
Illinois. The notice was published in the
Federal Register on July 14, 2006 (71 FR
40159).
At the request of a company official,
the Department reviewed the
certification for workers of the subject
firm. The workers were engaged in the
production of industrial consumer
package materials including multi-wall
bags.
All workers of Bemis Company, Inc., Paper
Packaging Division, including on-site leased
workers of Westaff, Peoria, Illinois, who
became totally or partially separated from
employment on or after April 25, 2005,
through June 8, 2008, are eligible to apply for
adjustment assistance under section 223 of
the Trade Act of 1974, and are also eligible
to apply for alternative trade adjustment
assistance under section 246 of the Trade Act
of 1974.
Signed at Washington, DC this 1st day of
August 2007.
Linda G. Poole,
Certifying Officer, Division of Trade
Adjustment Assistance.
[FR Doc. E7–15536 Filed 8–8–07; 8:45 am]
BILLING CODE 4510–FN–P
DEPARTMENT OF LABOR
Employment and Training
Administration
Investigations Regarding Certifications
of Eligibility To Apply for Worker
Adjustment Assistance and Alternative
Trade Adjustment Assistance
are identified in the Appendix to this
notice. Upon receipt of these petitions,
the Director of the Division of Trade
Adjustment Assistance, Employment
and Training Administration, has
instituted investigations pursuant to
section 221 (a) of the Act.
The purpose of each of the
investigations is to determine whether
the workers are eligible to apply for
adjustment assistance under Title II,
Chapter 2, of the Act. The investigations
will further relate, as appropriate, to the
determination of the date on which total
or partial separations began or
threatened to begin and the subdivision
of the firm involved.
The petitioners or any other persons
showing a substantial interest in the
subject matter of the investigations may
request a public hearing, provided such
request is filed in writing with the
Director, Division of Trade Adjustment
Assistance, at the address shown below,
not later than August 20, 2007.
Interested persons are invited to
submit written comments regarding the
subject matter of the investigations to
the Director, Division of Trade
Adjustment Assistance, at the address
shown below, not later than August 20,
2007.
The petitions filed in this case are
available for inspection at the Office of
the Director, Division of Trade
Adjustment Assistance, Employment
and Training Administration, U.S.
Department of Labor, Room C–5311, 200
Constitution Avenue, NW., Washington,
DC 20210.
Signed at Washington, DC, this 31st day of
July 2007.
Ralph DiBattista,
Director, Division of Trade Adjustment
Assistance.
Petitions have been filed with the
Secretary of Labor under section 221 (a)
of the Trade Act of 1974 (‘‘the Act’’) and
APPENDIX
[TAA petitions instituted between 7/23/07 and 7/27/07]
Subject firm
(petitioners)
Location
Everbrite (State) ...................................................................
Gampco (Wkrs) ....................................................................
Chadron Shop Colorado Custom Hardware (Wkrs) ............
Kilpsch Audio Technologies (Wkrs) .....................................
Hypertronics Corporation (Comp) ........................................
Spectralink Corp/Polycom Inc. (State) .................................
Garden Grove, CA ................
North Adams, MI ...................
Chadron, NE .........................
Hope, AR ..............................
Hudson, MA ..........................
Boulder, CO ..........................
mstockstill on PROD1PC66 with NOTICES
TA–W
61853
61854
61855
61856
61857
61858
................
................
................
................
................
................
VerDate Aug<31>2005
18:25 Aug 08, 2007
Jkt 211001
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
E:\FR\FM\09AUN1.SGM
Date of
institution
09AUN1
07/23/07
07/23/07
07/23/07
07/23/07
07/23/07
07/23/07
Date of
petition
07/12/07
07/20/07
07/17/07
07/23/07
07/19/07
07/19/07
]]>Agencies
[Federal Register Volume 72, Number 153 (Thursday, August 9, 2007)]
[Notices]
[Pages 44861-44862]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E7-15507]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
Manufacturer of Controlled Substances; Notice of Registration
By Notice dated March 9, 2007, and published in the Federal
Register on March 23, 2007 (72 FR 13825), Sigma Aldrich Research,
Biochemicals, Inc., 1-3 Strathmore Road, Natick, Massachusetts 01760,
made application by letter to the Drug Enforcement Administration (DEA)
to be registered as a bulk manufacturer of the basic classes of
controlled substances listed in schedule I:
------------------------------------------------------------------------
Drug Schedule
------------------------------------------------------------------------
Psilocybin (7437).......................... I
5-Methoxy-N,N-diisopropyltyptamine (7439).. I
------------------------------------------------------------------------
The company plans on manufacturing reference standards for research
purposes only.
No comments or objections have been received. DEA has considered
the factors in Title 21, United States Code (U.S.C.) 823(a) and
determined that the registration of Sigma Aldrich Research,
Biochemicals, Inc. to manufacture the listed basic class of controlled
substance is consistent with the public interest at this time. DEA has
investigated Sigma Aldrich Research, Biochemicals, Inc. to ensure that
the company's registration is consistent with the public interest. The
investigation has included inspection
[[Page 44862]]
and testing of the company's physical security systems, verification of
the company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to Title 21,
U.S.C. 823, and in accordance with Title 21, Code of Federal
Regulations (CFR) 1301.33, the above named company is granted
registration as a bulk manufacturer of the basic class of controlled
substance listed.
Dated: August 1, 2007.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E7-15507 Filed 8-8-07; 8:45 am]
BILLING CODE 4410-09-P
